Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta‐analysis

Abstract Introduction Several landmark randomized‐controlled trials (RCTs) have demonstrated the efficacy of sodium‐glucose co‐transport 2 (SGLT2) inhibitors in reducing all‐cause mortality, cardiovascular (CV) mortality and heart failure (HF) hospitalizations. Much interest surrounds their mechanis...

Full description

Bibliographic Details
Published in:ESC Heart Failure
Main Authors: Patrick Savage, Chris Watson, Jaimie Coburn, Brian Cox, Michael Shahmohammadi, David Grieve, Lana Dixon
Format: Article
Language:English
Published: Wiley 2024-12-01
Subjects:
heart failure
SGLT2 inhibitors
cardiac imaging
remodelling
biomarkers
Online Access:https://doi.org/10.1002/ehf2.14993

Internet

https://doi.org/10.1002/ehf2.14993

Similar Items